Related Experiment Video
Updated: Jul 20, 2026
10:03
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
The aggregation and fibrillation of alpha-synuclein
1Department of Chemistry and Biochemistry, University of California, Santa Cruz, California 95064, USA. enzyme@cats.ucsc.edu
Accounts of Chemical Research
|September 20, 2006
Summary
Alpha-synuclein aggregation is key in Parkinson's disease (PD). This study explores factors influencing alpha-synuclein
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Alpha-synuclein aggregation is implicated in Parkinson's disease pathogenesis.
- The protein is intrinsically disordered and abundant in presynaptic terminals.
- Fibrillation kinetics suggest a nucleation-dependent mechanism involving intermediates.
Purpose of the Study:
- To investigate the molecular basis of alpha-synuclein aggregation and fibrillation.
- To identify factors that modulate alpha-synuclein aggregation kinetics.
- To understand the role of different conformational and oligomeric states.
Main Methods:
- Review of investigations into alpha-synuclein aggregation.
- Analysis of factors including molecular crowding, oxidation, mutations, and lipid membranes.
- Examination of protein conformational and oligomeric states.
Main Results:
- Identified factors that accelerate or inhibit alpha-synuclein fibrillation.
- Characterized various conformational and oligomeric states of alpha-synuclein.
- Highlighted the importance of maintaining a balance of factors controlling alpha-synuclein levels and aggregation.
Conclusions:
- Neuronal cells require a delicate balance to regulate alpha-synuclein.
- Understanding aggregation mechanisms is crucial for Parkinson's disease research.
- Transient oligomers may play a role in the toxicity of aggregated alpha-synuclein.
More Related Videos
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:11Fibril-associated Collagen
Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...